Enzo Biochem, Inc.
ENZB
$0.4899
-$0.0001-0.02%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.54M | -3.38M | -13.38M | -3.02M | -3.06M |
| Total Depreciation and Amortization | 318.00K | 319.00K | 398.00K | 337.00K | 267.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 513.00K | 445.00K | 3.46M | 1.25M | -387.00K |
| Change in Net Operating Assets | -1.32M | -6.38M | 8.44M | -1.43M | -5.76M |
| Cash from Operations | -2.03M | -8.99M | -1.09M | -2.86M | -8.94M |
| Capital Expenditure | -70.00K | -448.00K | -123.00K | -143.00K | -25.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 5.00M | -- | -- | -- |
| Cash from Investing | -70.00K | 4.55M | -123.00K | -143.00K | -25.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -37.00K | -3.61M | -37.00K | -22.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00 | -163.00K | 0.00 | -7.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.32M | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -5.32M | -200.00K | -3.61M | -44.00K | -22.00K |
| Foreign Exchange rate Adjustments | -18.00K | 2.00K | 32.00K | -36.00K | 19.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.44M | -4.64M | -4.79M | -3.09M | -8.97M |